LRMR
Larimar Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.73
+7.64%Research · Sep 3, 2026
LRMR: FY25 Deep Dive
Larimar Therapeutics FY25 at $0M. NI $-166M; EPS $-2.27.
NASDAQ · Healthcare · Biotechnology · US
Research · Sep 3, 2026
Larimar Therapeutics FY25 at $0M. NI $-166M; EPS $-2.27.